Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients

Author： Santoro Ana   Felipe Claudia R   Tedesco-Silva Helio   Medina-Pestana Jose O   Struchiner Claudio J   Ojopi Elida B   Suarez-Kurtz Guilherme  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.9, 2011-09, pp. : 1293-1303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Calcineurin Inhibitors in Pediatric Renal Transplant Recipients

By Filler Guido  

Pediatric Drugs, Vol. 9, Iss. 3, 2007-01 ,pp. : 165-174

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients

By Moes Dirk Jan A.R.   Press Rogier R.   >  

Clinical Pharmacokinetics, Vol. 51, Iss. 7, 2012-07 ,pp. : 467-480

Adis International

Access to resources Recommend Favorite

Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors’’ dose requirements and trough blood levels in stable renal transplant patients

By Elens Laure   van Schaik Ron H   Panin Nadtha   de Meyer Martine   Wallemacq Pierre   Lison Dominique   Mourad Michel   Haufroid Vincent  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1383-1396

Future Medicine

Access to resources Recommend Favorite

Calcineurin Inhibitors and Post-Transplant Hyperlipidaemias

By Moore R.  

Drug Safety, Vol. 24, Iss. 10, 2001-01 ,pp. : 755-766

Adis International

Access to resources Recommend Favorite

Calcineurin inhibitors/mycophenolate mofetil/sirolimus: Proteinuria in renal transplant recipients: 7 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1255, 2009-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite